The Human Immunodeficiency Virus (HIV) is a virus that infects and kills the cells of your immune system. This infection eventually leads to the Acquired Immune Deficiency Syndrome (AIDS). An important aspect in preventing infection is to study how HIV enters immune cells and how infection spreads. Our lab is researching drugs to block the entry of HIV in immune cells, which can hopefully be used together with existing anti-HIV drugs to slow down the spread of the virus and the onset of AIDS.
Using A Novel Assay That Detects Antigen Specific CD4+ And Regulatory T Cells To Further Understand Reconstitution Of Antigen Specific Immune Response Post Anti-retroviral Therapy In Subjects With HIV And In The Diagnosis Of Latent TB
Funder
National Health and Medical Research Council
Funding Amount
$102,780.00
Summary
The process by which the immune system recovers after commencement of therapy for HIV is not well understood. We will use a new test to monitor the immune system's ability to recognise and react to different antigens inorder to understand the factors that affect immune recovery in patients on therapy for HIV. We will also evaluate the use of this new test in the diagnosis of latent TB. Improvement in detection will lead to treatment of latent TB thus reduction of cases of active TB.
The Impact Of Male Circumcision And Penile Modification Practices On Women In Papua New Guinea, Including Women's Risk Of HIV Transmission.
Funder
National Health and Medical Research Council
Funding Amount
$95,313.00
Summary
This grounded theory study will investigate the impact of male circumcision and penile modification practices on women in PNG, including women�s risk of HIV. The study aims to describe women�s understanding and experience of male circumcision and penile modifications and the processes they use to manage the outcomes of male circumcision. Implications for national HIV policy in Papua New Guinea will be identified. This study will be supported by researchers in Papua New Guinea and Australia.
Memory CD4 T Cells That Harbour The Reservoir Of Latent HIV Infection: Their Antigen Specificity, Function And Frequency Of Antigen-drivien Reactivation
Funder
National Health and Medical Research Council
Funding Amount
$133,351.00
Summary
Current antiretroviral therapy for HIV-1 infection is able to suppress viral replication, but cannot eradicate it completely. Upon cessation of antiviral therapy, viral recrudescence is prompt, and most likely arises from latent reservoirs of HIV in various cellular compartments. The aim of this research is to characterise which subsets of CD4 T cells that are the target of HIV infection harbour HIV infection, including describing their function and individual target antigen specificities.